Notice: amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `pre_get_posts` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the theme with slug `publisher` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/runcloud/webapps/techilive/wp-includes/functions.php on line 5313
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021 - TechiLive.in

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021

0

Geneva, Switzerland and Boston, MA – May 31, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that shareholders approved all Board proposals at its 2021 Annual General Meeting held on May 28, 2021.

 

The approved items are as follows:

Loading...
  1. Shareholders approved the Annual Report, the Statutory Financial Statements and the Consolidated Financial Statements for Fiscal Year 2020
  2. Shareholders granted discharge to the Members of the Board of Directors and to the Executive Committee for year 2020
  3. Shareholders approved the proposed appropriation of the Financial Results for year 2020
  4. Shareholders approved the proposed elections to the Board of Directors and election of the Chairman of the Board of Directors
  5. Shareholders approved the proposed elections to the Compensation Committee
  6. Shareholders approved the re-election of PricewaterhouseCoopers SA as ObsEva SA’s Auditors and Independent Registered Public Accounting Firm
  7. Shareholders approved the re-election of Perréard de Boccard SA as Independent Representative
  8. Shareholders approved the proposed compensation of the Board of Directors and the Executive Committee
  9. Shareholders approved the proposed increase of ObsEva SA’s Authorized Share Capital
  10. Shareholders approved the proposed increase of ObsEva SA’s Conditional Share Capital for Financing Purposes
  11. Shareholders approved the proposed increase of ObsEva SA’s Conditional Share Capital for Equity Plans
  12. Shareholders approved the proposed change to ObsEva SA’s Equity Incentive Plan

 

For a detailed agenda, including items submitted to shareholders’ vote and related proposals of the Board of Directors, please refer to the full invitation, which may be found in the Investors / General Meetings section of the company’s website www.ObsEva.com

To access the general meetings section of the Company’s website, please click here.

Loading...

To access the AGM 2021 section of the general meetings section directly, please click here.

To access the full invitation to the AGM 2021 directly, please click here.

 

Loading...

About ObsEva
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

 

For further information, please contact:

Loading...

 

CEO Office Contact:

Shauna Dillon

Loading...

Shauna.dillon@obseva.ch

+41 22 552 1550

Investor Contact:

Loading...

Joyce Allaire

jallaire@lifesciadvisors.com

+1 (617)-435-6602

Loading...

#

 

 

Loading...

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 

Loading...

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – admin@techilive.in. The content will be deleted within 24 hours.

Loading...
Leave a comment